MedTrace Logo

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants

NCT00130819 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-04-15

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of two approaches to treating HIV-infected patients who are addicted to opioid drugs (e.g., heroin) in an inner-city HIV clinic. The two approaches are:

* Case management and referral - participants are managed by a case manager and referred to a specialized drug treatment center where they receive counseling and medications for opioid-dependence (e.g., methadone or buprenorphine); or
* Clinic-based treatment - participants receive counseling and treatment with buprenorphine at the HIV clinic.

Conditions

  • Opiate Dependence
  • HIV Seropositivity
  • HIV Infections

Interventions

BEHAVIORAL

Clinic-based substance abuse treatment with buprenorphine

Subjects receive integrated opioid-dependence treatment with buprenorphine/naloxone at the HIV clinic

BEHAVIORAL

Case management and referred substance abuse treatment

Subjects receive case management and referral to an off-site opioid treatment program for their opioid dependence

Sponsors & Collaborators

Principal Investigators

  • Gregory M Lucas, MD, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00130819 on ClinicalTrials.gov